World's Largest Resource for Cardiovascular Perfusion

Perfusion NewswirePress ReleaseLeiters Press Release COVID-19

Leiters Press Release COVID-19

Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations, continues to closely monitor the evolving COVID-19 situation and the potential healthcare drug shortages. Several Group Purchasing Organizations1 have recently surveyed their members and identified commonly used drugs that are in high demand and are close to, or are already, in a shortage. Here’s a list of some of the drugs that have specifically been referenced:


Dexmedetomidine, Ketamine, Midazolam


Hydromorphone, Fentanyl, Morphine

Neuromuscular Blockers:

Rocuronium, Succinylcholine

Leiters offers various presentations of these drugs (and others). As demand has rapidly increased, inventory is limited. We are currently shifting our production to the most critical and requested medications. If you are in need of these products (or others) please reach out to us at 800.292.6772 to check availability and/or secure your inventory today. We’ve been working with many hospitals, health systems and Group Purchasing Organizations to gather as much information as we can, however please contact us directly with your needs so we can plan accordingly.

Leave a Reply

#1 largest online community of Perfusionists

Join Our
Online Community

Get your swag kit by becoming a member or updating profile.
Swag will be sent to U.S. mailing addresses only.

©2023 Perfusion. All Rights Reserved. Privacy Policy